MedTrace Logo

Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)

NCT00420173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2013-12-12

No results posted yet for this study

Summary

Cutaneous lupus erythematosus (CLE) is a disease with a wide spectrum of clinical manifestations and a variable prognosis. The aim of this study is to create a standardized evaluation of the different subtypes of this disease in order to receive an overview of the spectrum of clinical and laboratory features as well as the therapeutic strategies for patients with CLE.

Conditions

  • Cutaneous Lupus Erythematosus

Interventions

PROCEDURE

Laboratory analysis

blood withdrawal

Sponsors & Collaborators

  • European Society of Cutaneous Lupus Erythematosus e.V.

    lead OTHER

Principal Investigators

  • Annegret Kuhn, MD · Universität Münster

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2005-07-31
Completion
2008-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00420173 on ClinicalTrials.gov